Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (81-90 of 287) with videos related to

Pageof 29
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2013
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertensionKeith C Ferdinand, Samar A Nasser
Ethnicity & Disease|January 16, 2010
Eliminating disparities in hypertension, metabolic syndrome, kidney failure, and cardiovascular disease: basic science, clinical practice and community initiatives. ForewordKeith C Ferdinand, Keith C Norris
Circulation|December 29, 2018
Uncontrolled Hypertension in Black MenKeith C Ferdinand, Rachel M Graham
Progress in Cardiovascular Diseases|December 30, 2019
Hypertension 2020 update: A view from the Crescent City and beyondKeith C Ferdinand, Carl J Lavie
International Journal of Cardiology|November 29, 2018
Disparities in hypertension and cardiovascular disease in African Americans: Is the answer in the gut microbiota?Keith C Ferdinand, Rachel M Graham
Current Hypertension Reports|July 24, 2025
Introduction: A Renewed Focus on Disparities in Hypertension Identification, Treatment, and ControlTina K Reddy, Keith C Ferdinand
Current Hypertension Reports|March 11, 2015
Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive PatientKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|January 17, 2012
Hypertension in the US Black population: risk factors, complications, and potential impact of central aortic pressure on effective treatmentKeith C Ferdinand, Raymond R Townsend
Cardiology Clinics|April 17, 2017
Management of Essential HypertensionKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|June 13, 2015
PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)Keith C Ferdinand, Samar A Nasser
Pageof 29

Showing results (81-90 of 287) with videos related to

Sort By:
Pageof 29
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2013
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertensionKeith C Ferdinand, Samar A Nasser
Ethnicity & Disease|January 16, 2010
Eliminating disparities in hypertension, metabolic syndrome, kidney failure, and cardiovascular disease: basic science, clinical practice and community initiatives. ForewordKeith C Ferdinand, Keith C Norris
Circulation|December 29, 2018
Uncontrolled Hypertension in Black MenKeith C Ferdinand, Rachel M Graham
Progress in Cardiovascular Diseases|December 30, 2019
Hypertension 2020 update: A view from the Crescent City and beyondKeith C Ferdinand, Carl J Lavie
International Journal of Cardiology|November 29, 2018
Disparities in hypertension and cardiovascular disease in African Americans: Is the answer in the gut microbiota?Keith C Ferdinand, Rachel M Graham
Current Hypertension Reports|July 24, 2025
Introduction: A Renewed Focus on Disparities in Hypertension Identification, Treatment, and ControlTina K Reddy, Keith C Ferdinand
Current Hypertension Reports|March 11, 2015
Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive PatientKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|January 17, 2012
Hypertension in the US Black population: risk factors, complications, and potential impact of central aortic pressure on effective treatmentKeith C Ferdinand, Raymond R Townsend
Cardiology Clinics|April 17, 2017
Management of Essential HypertensionKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|June 13, 2015
PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)Keith C Ferdinand, Samar A Nasser
Pageof 29